An announcement from Bluebird Bio (BLUE) is now available.
Bluebird bio, Inc. faces delays in filing its crucial financial reports due to restatements needed in their previous financial statements. The company has received notices from Nasdaq for non-compliance related to timely filing requirements and is working on a compliance plan to regain its standing. With granted extensions, they aim to submit all required documentation within the new deadlines and have communicated these developments publicly as per Nasdaq rules. Their securities remain listed as they work towards resolving these reporting issues.
Learn more about BLUE stock on TipRanks’ Stock Analysis page.
